ERG and prostate neoplasm: Furthermore, additional analyses performed by Ren and colleagues on 54 prostate tumor samples confirmed the presence of TMPRSS2-ERG fusion in Chinese population at lower frequency (about 20%) with respect to that observed in Caucasian patients [30].